Peroxisome proliferators are non-mutageni c carcinogens in the liver of rodents, acting both as initiators and promoters. The National Toxicology Program (NTP) conducted a study of several peroxisome proliferators (PPs), including Wyeth (WY)-14643 as a prototypical PP and 2,4-dichlorophenoxyaceti c acid (2,4-D) as a weak PP, in Sprague-Dawley rats, B6C3F1 mice, and Syrian hamsters. In the kidney, an unusual change was observed in the outer stripe of the outer medulla, especially in rats treated with 2,4-D or WY-14643. This change was characterized by foci of tubules that were partially or completely lined by basophilic epithelial cells with decreased cytoplasm and high nuclear density. Changes typical of chronic nephropathy such as interstitial brosis or basement membrane thickening were not associated with these foci. Results of immunohistochemical staining for catalase and cytochrome P-450 4A in the kidney indicated increased staining intensity in renal tubular epithelial cells primarily in the region where the affected tubules were observed; however, the altered cells were negative for both immunohistochemica l markers. Ultrastructurally, affected cells had long brush borders typical of the P3 tubule segment. The most distinguishing ultrastructural change was a decreased amount of electronlucent cytoplasm that contained few differentiated organelles and, in particular, a prominent reduced volume and number of mitochondria; changes in peroxisomes were not apparent . In addition to the lesion in rats, mice treated with the highest dose of 2,4-D, but not WY-14643, manifested similar renal tubular changes as seen by light microscopy. Neither chemical induced renal tubular lesions in hamsters. Hepatocellular changes characteristic of PPs were present in all 3 species treated with WY-14643, but not 2,4-D. These results indicate that the rat is the species most sensitive to the nephrotoxic effects of PPs and there is a site speci city to this toxicity related to areas of PP-related enzyme induction. Although 2,4-D is considered a weak PP for the liver, it was the most effective at inducing renal lesions, indicating that the toxic potency of various PPs will depend on the target organ.
INTRODUCTION
Peroxisome proliferators constitute a diverse group of chemicals that includes several therapeutically used drugs, plasticizers, and organic solvents used in the chemical industry and found in herbicides and naturally occurring hormones (14) . Peroxisome proliferators constitute a novel class of nonmutagenic carcinogens that act as both initiators and promoters in the liver (29) . Hepatocellular tumors and altered liver cell foci have been readily induced in rats and mice of both sexes after long-term oral administration (19) . Peroxisome proliferators cause an increase in the number and size of peroxisomes, not only in the liver but also in the kidney and heart of susceptible species (14) . WY-14643 strongly induces peroxisomes in the rodent liver (12, 21) , however, 2,4-D, the oxidized active metabolite of the herbicide 2,4-dichlorophenoxybutyli c acid (2, , is known to be a weak peroxisome proliferator in rodents (1, 18, 22, 35) .
Peroxisome proliferators function in the liver and kidney as co-inducers of cytochrome P-450 4A-dependent fatty acid hydroxylases and lipid b -oxidation enzymes, like catalase and palmitol-CoA oxidase, enzymatic markers of peroxisomes (27, 30, 37) . The transcriptional activation of both cytochrome P-450 and lipid b -oxidation enzymes is medi-ated by members of the nuclear receptor superfamily called the peroxisome proliferator-activated receptors (PPARs). A strong correlation between the proliferation of peroxisomes, induction of P450 4A and levels of PPARs has been reported in rodent liver (24) . Among the isoforms of PPARs, PPARa is expressed highly in hepatocytes and to a lesser extent in cardiomyocytes, enterocytes, and the proximal tubules of the kidney (2, 5) . In contrast, PPARc is expressed predominantly in adipose tissue and in the immune system and is present at low levels in liver (2, 5) , PPARb is more ubiquitously expressed and most abundant in the central nervous system (14) . This tissue-speci c pattern of expression is consistent with a role for PPARa, but not PPARc or PPARb, in peroxisome proliferator-induced rodent hepatocarcinogenesis (31) .
The National Toxicology Program (NTP) conducted a study of 4 peroxisome proliferators: WY-14643, 2,4-D, gembrozil, and dibutylphthalate. The aim of the study was to further characterize the toxicity pro le of dibuthylphthalate , which is present in the environment and constitutes a large potential human risk. The WY-14643 and gem brizol were used as positive controls, as both have been shown to produce considerable peroxisome proliferation and hepatocarcinogenicity in the rats. The 2,4-D, which is a weak peroxisome proliferator, was also tested to provide information to correlate with ongoing chronic study carried out by an industry task force. This study was performed in several species to evaluate the sensitivity and speci city of chemically induced changes. Rats and mice were chosen, as they are the species 440 0192-6233/01$3.00 $0.00 commonly used for peroxisome studies. Hamsters were also included because, like humans, they are considered to be relatively resistant to the effects of peroxisome proliferators. Only males were used because they have been found to be more sensitive to peroxisome proliferators than females.
Histopathological evaluation of the NTP study revealed an unusual lesion in the kidney of rats and mice treated with WY-14643 or 2,4-D. The purpose of this article is to describe the lesion and immunohistochemical and electron microscopic characterizations to elucidate its possible relationship to peroxisome proliferator activity.
MATERIALS AND METHODS

Study Design and Light Microscopic Examination
Male Harlan Sprague-Dawley rats, B6C3F1 mice, and Syrian hamsters were received from Harlan Sprague-Dawley Inc (Indianapolis, IN). Taconic Farms Inc (Germantown, NY), and Frederick Cancer Research and Development Center (Frederick, MD), respectively. WY-14643 was received from Chemsyn Science Laboratories (Lenexa, KS) and 2,4-D was purchased from Sigma Chemical Co (St. Louis, MO). After a quarantine period of 12 to 18 days, rats, mice, and hamsters were placed in the study at approximately 6-8 weeks of age. Rats were housed 5/cage and mice and hamsters individually during the quarantine and study periods. Animal room controls were set to maintain a temperature of 72 3 F and a relative humidity of 50 15%. Water from the Columbus, Ohio, municipal supply and the NTP-2000 diet (Zeigler Brothers, Inc, Gardners, PA) in meal form to which the appropriate amount of test article had been added were available ad libitum. All procedures, maintenance, and treatment of rats, mice, and hamsters were in accordance with the principles of humane treatment described by the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The NTP selected the treatment dose level according to the result of preliminary 14-day study of each chemical.
Groups of 10 male animals/species were treated with the same doses of WY-14643 at 0, 5, 10, 50, 100, and 500 ppm in the feed for 3 months. Groups of 10 male animals/species were administered 2,4-D in the feed for 3 months at different dosages: 0, 17, 83, 250, 750, 1,250, and 2,500 ppm for rats; 0, 12, 28, 83, 250, 700, and 1,680 ppm for mice; and 0, 12, 100, 500, 1,000, and 5,000 ppm for hamsters. After euthanasia, organs were xed in 10% neutral buffered formalin for 48 hours, embedded in paraf n, sectioned, and stained with hematoxylin and eosin (H&E). Severity grades for simple hyperplasia were based on the proportion of the area occupied by the altered tubules in the outer stripe of the outer medulla of the kidney. Severity grades for chronic nephropathy were based on the proportion of area of the renal parenchyma that exhibited the tissue changes in the whole kidney. The severity of lesions was graded using a 4-point score of minimal 1 (up to 25%), mild 2 (26-50%), moderate 3 (51-75%), and marked 4 (more than 75%).
Electron Microscopic Examination
Small samples (1 mm 3 ) of formalin-xed rat kidney tissue from the 2,4-D study were prepared for electron microscopy by immersion-xation in 3% glutaraldehyde and post xation in 2% OsO 4 , both buffered in 0.1M sodium cacodylate, pH 7.2; en bloc staining in 2% aqueous uranyl acetate; dehydration through a series of graded alcohols; and embedment in Poly/Bed 812 epoxy resin (Polysciences, Inc, Washington, PA). Semithin (0.5 l m) sections were cut preliminarily from the embedded tissue and stained with toluidine blue to determine the appropriate areas for ultrastructural examination. Ultrathin sections (80-90 nm) were placed on collodion-and carbon-coated copper grids, stained with 5% aqueous uranyl acetate and Reynold's lead citrate and examined in a Philips EM 400 electron microscope (N V Philips, Eindhoven, The Netherlands).
Immunohistochemical Staining
Immunohistochemistry was performed on selected control and treated rats to determine treatment effects on cell proliferation and peroxisome proliferator-related enzyme induction. Paraf n-embedded sections of liver and kidney were obtained from 5 control and 5 test animals treated with 2,500 ppm 2,4-D or 500 ppm WY-14643 for 3 months. Immunohistochemistry was performed using the avidin-biotin-peroxidas e method. Tissue sections were stained with one of the following antibodies: catalase (The Binding Site, Birmingham, England) or P-450 4A (Amersham Life Science, Piscataway, NJ). Following dehydration through a series of graded alcohols, all slides were placed in 1X automation buffer (AB) (Biomeda, Foster City, CA) then in 3% H 2 O 2 (vol/vol) for 15 minutes to block endogenous peroxidase. Heat-induced epitope retrieval was not necessary for either antibody. Slides stained for both catalase and P-450 4A were blocked in 5% normal rabbit serum (Jackson Immunoresearch, West Grove, PA). A working dilution of 1:500 was prepared for catalase and 1:400 for P-450 4A. Normal sheep serum (Jackson Immunoresearch) was used in place of the primary antibodies for the negative control. Slides were incubated for 1 hour at room temperature and washed in 1X AB followed by a 30-minute incubation with biotinylated rabbit anti-sheep lgG (Vector Laboratories, Burlingame, CA) at a 1:500 dilution. Slides were washed again and incubated with Elite AvidinBiotin Complex (Vector Labs) for 30 minutes. All slides were then washed twice in 1X AB. Visualization of the antibody complex was performed using Dako Liquid DAB TM (Dako, Carpinterina, CA) for 6 minutes. After counterstaining for 30 seconds with Harris hematoxylin (Harleco, Gibbstown, NJ), slides were rehydrated through a series of graded alcohols and coverslipped with Permount (Surgipath, Richmond, IL).
The catalase and P450 4A immunohistochemical staining was scored blindly. A semiquantitative assessment was used to estimate the level of immunohistochemical staining in 3 different anatomical compartments of the kidneys (ie, cortex, outer stripe of the outer medulla, inner stripe, and inner zone of the medulla). The following scoring method adapted from Detre et al (10) was used to assess both the staining intensity as well as the percentage of cells staining positively:
The staining intensity (SI) of the epithelial cells in the 3 different anatomical compartments was scored as 0, 1, 2, or 3 corresponding to the presence of negative, weak, intermediate or strong brown staining, respectively. Additionally, a 3.5 grade was assigned when a slightly stronger staining expression than grade 3 was noted.
The proportion of the area occupied by positive epithelial cells (PE) out of the entire area was scored as: 0: 1-5%; 1: 6-25%; 2: 26-50%; 3: 51-75%; 4: 76-100%.
The net score was then calculated by multiplying intensity (SI) proportion (PE).
Proliferating cell nuclear antigen (PCNA) staining was performed in the kidney of rats by previously described methods (11) . Kidney sections were obtained from 5 randomly selected rats from the control and high dose groups (2,500 ppm 2,4-D; 500 ppm WY-14643). Tissue sections were incubated with a monoclonal antibody to PCNA (Dako Corp, Carpenteria, CA) and reagents required for the avidin-biotin peroxidase (Vactastain ABC peroxidase kit, Vector Laboratories) method for the detection of the antigen-antibody complex. PCNA expression was localized by the chromagen 3,3 -diaminobenzidine tetrahydrochloride (DAB, Sigma Chemical Co.).
Statistical Analyses
Pairwise dosed group vs control comparisons of body weight and organ weight were made by Dunnett's test (23) . Mann-Whitney U -tests were used to compare 2,4-D and control groups with regard to the scoring of immunohistochemical staining. Comparisons of the incidences of nonneoplastic lesions were made by Fisher's exact tests (34) .
RESULTS
Body Weight
For groups treated with WY-14643, body weights were signi cantly ( p < 0.05) reduced in hamsters receiving doses of 10 ppm and higher, in rats receiving doses of 50 ppm and higher, and in mice receiving doses of 100 ppm and higher. In the 500 ppm group, the mean body weight reductions ranged from 22% (mice) to 35% (hamsters). For 2,4-D, the only signi cant body weight effect was an 18% reduction in body weight observed in the top-dose (1680 ppm) group of mice.
Organ Weights
In WY-14643 treated rats, mice, and hamsters, absolute and relative liver weights were signi cantly ( p < 0.05) greater in all treated groups, and the increases were generally doserelated. The relative kidney weights of all WY-14643-treated rats and hamsters, but not mice, were also signi cantly increased in a dose-related manner. In the 2,4-D studies, the only signi cant liver weight change occurred in high dose (1680 ppm) mice. Relative kidney weights were increased in rats at doses of 750 ppm and higher, although the increases were not clearly dose-related.
Light Microscopy
In the light microscopic evaluation of kidneys from this series of peroxisome proliferator studies, a distinctive morphologic alteration diagnosed as simple hyperplasia was seen in the renal tubules of rats and mice treated with 2,4-D and WY-14643 for 3 months. As shown in the tabulated incidence/severity data (Table 1) , the effect was most evident in rats exposed to 2,4-D. Incidence and severity of this change increased in a dose-dependent manner in rats but occurred only in high-dose mice. In the WY-14643 study, only rats were affected in a nondose-dependent fashion. As shown in Figure 1A , simple hyperplasia was not noted in the outer stripe of the outer medulla of the control animals. The morphological alteration was restricted to the outer stripe of the outer medulla and consisted of a few scattered foci of tubules with prominent basophilia due to high nuclear density and decreased cytoplasmic volume of the epithelial cells. Quite characteristically, the affected cells often only partially lined the tubular circumference ( Figure 1B-C) . Only rarely, this change was associated with a minimal increased number of mesenchymal interstitial cells ( Figure 1D ). Simple hyperplasia was not noted in the kidney of any control animals and was morphologically distinct from the early stages of spontaneous chronic nephropathy occasionally found in controls. 2,4-D caused exacerbation of spontaneous nephropathy in hamsters, but simple hyperplasia was not induced by either WY-14643 or 2,4-D in this species.
In the liver, cytoplasmic alteration of the hepatocytes typical of peroxisome proliferator treatment, characterized by homogenous brightly eosinophilic granularity of hepatocytic cytoplasm, was seen in rats, mice and hamsters treated with WY-14643. On the other hand, 2,4-D produced no treatmentrelated lesion in the livers of rats, mice and hamsters.
Electron Microscopy
Affected tubules were identi ed by partially lining with small, electronlucent epithelial cells compared to the normal tubule (Figure 2A-B) . The height of these cells was diminished relative to that of the neighboring epithelial cells, but they possessed a similar well-developed brush border consistent with the P3 segment of the proximal tubule. The cytoplasm of the altered cells was markedly reduced in volume, and there was a prominent decrease in the number and volume 
Immunohistochemistry
Widely scattered tubular cell nuclei were positive for PCNA in both control and treated sections of kidney; however, there was no appreciable increase in PCNA positivity throughout the kidney section, and in particular the foci of altered tubular cells were uniformly negative for this marker. We attempted to nd supporting PCNA evidence of hyperplasia, but did not. However, the lack of PCNA immunostaining merely indicates that a replicative event was not occurring at the time of termination and does not rule out its occurrence previously. Likewise, the absence of mitotic gures at this time point does not preclude a mitogenic event at some time. Although there may be other explanations for the apparent increased number of cells in these foci, we feel use of the term hyperplasia to describe the change is appropriate for now in the absence of additional data. Furthermore, evidence for apoptosis was not present and therefore not mentioned; we feel that further assessment for this process is not justi ed in the absence of evidence in standard H&E-stained sections (12a).
The results for catalase and P450 4A immunoreactivity are presented in Table 2 and Figure 3A -H. Staining for these enzyme markers in the liver of rats treated with the strong peroxisome proliferator WY-14643 was considered the positive control, and widespread intense staining of the centrilobular region was evident for both P450 4A ( Figure 3A ) and catalase ( Figure 3C ). In contrast, immunostaining for the same markers was much less intense in centrilobular hepatocytes from rats treated with 2,4-D (Figure 3B and 3D ). In the kidney, some background immunoreactivity was evident for both P450 4A and catalase in control animals, particularly in the outer stripe of the outer medulla (Figure 3E and 3G; Table 2 ). In kidneys of rats treated with 2,4-D, this staining was intensied ( Figure 3F and 3H; Table 2 ). Statistical analysis of overall staining scores (SI PE values) indicated signi cantly b The proportion of epithelial cells (PE) staining positively in the 3 anatomical compartment s (C cortex, OSOM outer stripe of the outer medulla and ISOM inner stripe of the outer medulla and inner zone of the medulla) was scored as: 0:1-5%; 1:6-25%; 2:26-50%; 3:51-75%; 4:76-100%. greater staining in the outer stripe of the outer medulla for both P450 4A and catalase (Table 2) . That affected tubular epithelial cells were characteristically negatively for both enzyme markers is, however, noteworthy. DISCUSSION Although there is abundant literature concerning the hepatic effects of peroxisome proliferators, reports of the renal effects of this class of compounds, even for strong prototypical peroxisome proliferators such as WY-14643, are less numerous. Di(2-ethylhexyl)phthalate (DEHP) is one peroxisome proliferator known to be a renal toxicant, inducing papillary mineralization and exacerbated nephropathy following chronic exposure (9) . That the renal effects of DEHP are only partly abrogated in PPARa-null mice suggests that renal toxicity may be mediated by some PPARa-independent pathways (36) .
There are several reports of renal toxicity by the weak peroxisome proliferator 2,4-D, and the various histopathological effects in the kidney of different species are shown in Table 3 (6-9, 13, 25, 28). Particularly noteworthy is the study of Gorzinski et al (15) , which reports renal effects in F344 rats treated with 0, 15, 60, 100, and 150 mg/kg/day 2,4-D for 13 weeks. A dose-related change characterized as being "degenerative" was identi ed in the proximal tubule of treated male rats and described as foci of "basophilic epithelial cells that were crowded because of decreased cytoplasm. Typically, the degeneration involved only a portion of the circumference of an affected tubule." No association was made with peroxisome proliferation in this reference; however, the lesion described is morphologically similar to that we have characterized as simple hyperplasia in the present subchronic studies with the peroxisome proliferators 2,4-D or WY-14643. This change is distinguished from tubular hyperplasia associated with chronic nephropathy by the extension of the basophilic cells only partially, not completely, around the tubule and by the lack of basement membrane thickening or interstitial in ammation. Other signi cant features of this lesion were its localization in the outer stripe of the outer medulla (P3 tubule segment) and its greater severity in rats compared to mice and in animals treated with 2,4-D compared to those treated with WY-14643.
Hard et al (17) reported that hyperplasia of renal tubule epithelium implies an increase in the number of lining cells but without proliferation beyond the well-de ned, basement membrane-bound integrity of the individual tubule structure and can be subdivided into the morphological categories of simple and atypical. Renal tubular change observed in this study was morphologically consistent with the simple tubular hyperplasia, in which, there is an increase in the number of epithelial cells, but the single cell layer of the lining is maintained. The tubule with simple hyperplasia may or may not exceed normal dimensions or may be slightly smaller due to decreased cell size. Simple hyperplasia observed in the rat treated with the peroxisome proliferators, WY-14643 or 2,4-D, also maintained the single cell layer, lacked cell growth beyond the basement membrane, and contained high nuclear density due to smaller cell size.
The difference between simple hyperplasia described by Hard et al and the simple hyperplasia in affected tubules found in the present study was the degree of extension of the crowded cells around the tubules. In the kidneys of the rats treated with peroxisome proliferators, in most cases the affected cells involved only partially the circumference of the tubules, rather than the full circumference as described by Hard et al. Furthermore, in simple hyperplasia observed in early stages of chronic progressive nephropathy, the affected tubules are usually located in the cortex; however, in the case of peroxisome proliferator-induced simple hyperplasia, the affected tubules were restricted to the outer stripe of the outer medulla of the kidney. Although we de ned the lesion observed in this study as simple hyperplasia, we suggest that simple hyperplasia could be subdivided into 2 categories of simple hyperplasia, involving either part or the entire circumference of the tubule (Figure 4 ). Our study presents a new morphological aspect of renal tubular hyperplasia noted in rats and mice treated with selected peroxisome proliferators. Whether these changes have the potential to progress further is unknown; however, a 2-year chronic toxicity and carcinogenicity study in Osborne-Mendel rats at dietary levels of 0, 5, 25, 125, 625, or 1,250 ppm did not show any carcinogenic response for 2,4-D (16) . In mice of the present study, the tubular change was observed in the kidneys treated with highest dose of 2,4-D; however, this lesion was not found in hamsters. The hyperplastic change in tubules may be explicable by the greater sensitivity of rat than mouse kidney to peroxisome proliferators and the reduced sensitivity of hamster kidney and liver compared to these organs in rat and mouse.
Immunohistochemical and biochemical investigations have been used to localize and measure the activity of peroxisomal enzymes such as catalase and P-450 4A in the liver and kidney (3, 30) . The change in renal fatty acid-oxidizing enzymes has been investigated following short-term exposure to a group of structurally diverse peroxisome proliferators and compared to the more extensively documented hepatic responses in the rat (33) . Results indicated that the kidney was more refractory to induction of the endoplasmic reticulum and peroxisomal fatty acid-oxidizing enzymes than the liver. Intraperitoneal administration of the peroxisome proliferators clo brate, DEHP, and 2,4-D to sea bass was associated with strong induction of cytochrome P450 in the kidneys (32) . The results of our immunohistochemical staining for catalase and P-450 4A demonstrated colocalization of both markers primarily in the outer stripe of the medulla of the rat kidney and a signi cant increase in expression of these enzymes detected immunohistochemically in animals treated with WY-14643 or 2,4-D for 3 months.
These results were similar to the ndings of Bell et al (4) in rats treated with the peroxisome proliferator methylclofenapate. Few reports have demonstrated morphological changes of cell hypertrophy or peroxisome proliferation in renal tubular epithelial cells such as those that occur in hepatocytes. In 1 report, dietary exposure of male mice to methylclofenapate was associated with signi cant increase in the number of single membrane-limited organelles in cells of the P1, P2, and P3 segments of the proximal convoluted tubule (30) . The cytochemical localization of catalase enabled their identi cation as peroxisomes; however, in the current study, no increase in peroxisome number was detected in the affected tubules, although organelle quanti cation was not a speci c aim of this study, and a subtle effect cannot be ruled out. In fact, the altered cells of affected tubules were smaller than their neighbors, lacked immunostaining for catalase or P450 4A, and exhibited reduced numbers of organelles-features opposite of those considered hallmarks of peroxisome proliferator exposure. What relationship if any these cells have to the neighboring cells with induced enzyme activity is not clear. We presume these are regenerative hyperplastic cells which proliferated following a cytotoxic effect possibly related to peroxisome proliferation.
Another possibility is that the focal hypercellularity observed in the renal tubules of this study was the result of mitogenic activation. The mitogenic response of the rodent liver to peroxisome proliferators is well known (14) . In the rat kidney, a single dose of several peroxisome proliferators, including 3,3 ,5-triiodo-L-thyronine (T 3 ), was associated with a 2.5-5-fold increase in the number of bromodeoxyuridinelabeled nuclei after 24 hours. The labeling occurred predominantly in epithelial cells of the proximal tubules. That the T 3 was acting as a direct mitogen and not leading to proliferation through a regenerative mechanism was suggested (26) . The peroxisome proliferator DEHP acts as a tumor promoter in the rat kidney following initiation with N -ethyl-N -hydroxyethylnitrosamine (EHEN) (20) ; on the other hand, clo brate and sim brate do not promote renal tumors under the same experimental conditions. In the present study, we conducted PCNA staining of the kidney of rats; however, an increase in the number of PCNApositive cells compared to the control was not observed even in the affected tubules (data not shown), indicating that the affected cells induced by WY-14643 or 2,4-D were not actively proliferating at the time of tissue sampling. Further cell proliferation studies are necessary to determine whether mitogenic or hyperplastic mechanisms are involved in the development of the unique tubular lesions described here.
n conclusion, we have described unique renal tubular changes in rats and mice treated with peroxisome proliferators. Although these lesions are not characterized by the typical morphological hallmarks of peroxisome proliferators, such as cell hypertrophy or peroxisome proliferation, they are interpreted to be the result of peroxisome proliferator activity and may be mediated by a PPARadependent mechanism, because they were induced by 2 structurally unrelated compounds and associated with increases in peroxisome proliferator-related enzyme markers. There was a lack of concordance, however, between the potency of the 2 compounds to stimulate peroxisome proliferation in liver and their ability to induce renal toxicity, because the weaker peroxisome proliferator in the liver, 2,4-D, caused more severe kidney changes. Whether the variable target organ susceptibility is due to differing PPAR af nities or receptor-independent, direct chemical mechanisms is unclear.
